, Geneva: World Health Organization, WHO. World malaria report, 2015.
Enquête sur les indicateurs du paludisme (EIP), 2015. ,
, Policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization, 2012.
, Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization, 2013.
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial, PLoS Med, vol.8, p.1000407, 2011.,
URL : https://hal.archives-ouvertes.fr/halshs-00681318
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticidetreated bednet in Burkina Faso: a randomised, double-blind, placebocontrolled trial, PLoS Med, vol.8, p.1000408, 2011. ,
A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment in children (IPTc), PLoS ONE, vol.6, p.16976, 2011. ,
Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study, Lancet Infect Dis, vol.16, pp.465-72, 2016. ,
Subnational targeting of seasonal malaria chemoprevention in the Sahelian countries of the Nouakchott Initiative, PLoS ONE, vol.10, p.136919, 2015. ,
Analysis of preventive interventions for malaria: exploring partial and complete protection and total and primary intervention effects, Am J Epidemiol, vol.181, pp.1008-1025, 2015. ,
, Mali Demographic and Health Survey, 2012.
Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method, Bull World Health Organ, vol.60, pp.253-60, 1982. ,
Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa, Am J Trop Med Hyg, vol.52, pp.565-573, 1995. ,
A molecular marker for chloroquine-resistant falciparum malaria, N Engl J Med, vol.344, pp.257-63, 2001. ,
Minimum wages and employment: a case study of the fast-food industry in New Jersey and Pennsylvania, Am Econ Rev, vol.84, pp.772-93, 1994. ,
Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial, Lancet, vol.367, pp.659-67, 2006. ,
Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malariainfected patients from Nigeria, Acta Trop, vol.95, pp.183-93, 2005. ,
, Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (IPTi-SP) for Plasmodium falciparum malaria control in Africa. Geneva: World Health Organization, 2010.
Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal, Malar J, vol.12, p.137, 2013. ,
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali, Malar J, vol.9, p.9, 2010. ,
Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxinepyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal, Parasitol Res, vol.109, pp.133-141, 2011. ,